Jefferies upgrades Summit Therapeutics to Buy from Hold
Benzinga (via TradingView News) reports Jefferies raised its rating on Summit Therapeutics from Hold to Buy.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.